Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:04 AM ET Form 4
Insider Buying Miniso Group Holding Ltd MNSO

Miniso Group Holding VP and CFO Jingjing Eason Zhang Buys $340K of Stock

Jingjing Eason Zhang, VP and CFO, bought 150,600 shares of Miniso Group Holding Ltd at $2.26 a share, worth $340K in total on Sep 29, 2026. Shares held after the trade: 394,474 (+61.8%).

Value
$340K
Shares
150,600
Price
$2.26
Role
VP and CFO
Holding change
+61.8%
Trade date
Sep 29, 2026
6:04 AM ET 8-K
Business Update Artificial Intelligence Technology Solutions Inc. AITX

Artificial Intelligence Technology Solutions Business Update

Artificial Intelligence Technology Solutions' subsidiary, RAD, received an additional order for one RIO 360 unit from an existing global healthcare technology client. This follows a previous order from the same customer earlier in the month and is intended for after-hours trespass deterrence at a second location.

Counterparty
unnamed global healthcare technology customer
6:04 AM ET 8-K
Other 8-K Filing DBV Technologies S.A. DBVT

DBV Technologies Other 8-K Filing

DBV Technologies has submitted a Biologics License Application (BLA) to the U.S. FDA for its VIASKIN Peanut Patch for children aged 4-7 years. The submission is based on positive Phase 3 VITESSE trial results and marks the company's transition toward a commercial-stage organization. The company has requested Priority Review for the application.

Counterparty
FDA
6:02 AM ET 8-K
Business Update Ares Management Corp ARES

Ares Management Business Update

Ares Management Corporation provided a preliminary estimate for its realized net performance income for the third quarter ending September 30, 2026. The company expects approximately $10 million in realized net performance income, a slight increase from the $9 million reported in the same period the prior year.

Term
Q3 2026
6:02 AM ET 8-K
Stock Buyback News Corp NWSA

News Announces $1B Stock Buyback

News Corp provided a daily update on its $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The program authorizes the company to buy back outstanding shares of both Class A and Class B common stock from time to time in the open market. The filing includes specific daily transaction notifications for Class A common stock repurchases.

Value
$1B
6:02 AM ET 8-K
Other 8-K Filing Invest Acquisition Corp IVCBF

Invest Acquisition Other 8-K Filing

Invest Acquisition Corp shareholders approved an amendment to extend the company's business combination deadline from December 17, 2027, to December 17, 2029. In connection with the extension, holders of 1,801,349 Class A ordinary shares elected to redeem their shares for approximately $22.2 million from the trust account.

6:01 AM ET 8-K
Other 8-K Filing IB Acquisition Corp. IBAC

IB Acquisition Other 8-K Filing

IB Acquisition Corp. (IBAC) held a special meeting where stockholders approved an extension to the deadline for completing its initial business combination from September 28, 2026, to March 28, 2027. The company filed a charter amendment to formalize this extension and updated its trust agreement to reflect the new liquidation and redemption timeline.

Term
6 months
6:01 AM ET 8-K
Shareholder Meeting Barnes & Noble Education, Inc. BNED

Barnes & Noble Education Shareholder Meeting

Barnes & Noble Education held its 2026 Annual Meeting of Stockholders on September 24, 2026, where shareholders elected six directors to the board. Stockholders also approved an amendment to the company's Equity Incentive Plan to increase the number of authorized shares, ratified the appointment of BDO USA, P.C. as independent auditors, and approved executive compensation on an advisory basis.

6:00 AM ET 8-K
Divestiture Reliance Global Group, Inc. XGPU

Reliance Global Group Divestiture to Altruis Benefit Management, LLC for $8M

Reliance Global Group's subsidiary, Altruis Benefit Consultants, sold substantially all assets of its employee benefits insurance agency business to Altruis Benefit Management, LLC for $8 million. The consideration consists of approximately $4.44 million in cash, a $3.1 million secured promissory note, and $461,729 in holdbacks, with potential earnout payments of up to $1 million based on future revenue growth. The transaction closed simultaneously with the signing of the asset purchase agreement on September 23, 2026.

Value
$8M
Counterparty
Altruis Benefit Management, LLC
6:00 AM ET 8-K
Capital Raise Stonepeak-Plus Infrastructure Fund LP

Stonepeak-Plus Infrastructure Fund Capital Raise of $52.7M

Stonepeak-Plus Infrastructure Fund LP sold unregistered limited partnership units to third-party investors for approximately $52.7 million on September 1, 2026. The sale was part of a continuous private offering that has raised approximately $1.92 billion since its inception in May 2025.

Value
$52.7M
Counterparty
Third party investors
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CFO Brandi Roberts Sells $123K of Stock

Brandi Roberts, CFO, sold 3,377 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $123K in total on Sep 25, 2026. Shares held after the trade: 394,528 (-0.8%).

Value
$123K
Shares
3,377
Price
$36.57
Role
CFO
Holding change
-0.8%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CLO Mark Sullivan Sells $514K of Stock

Mark Sullivan, CLO, sold 14,051 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $514K in total on Sep 25, 2026. Shares held after the trade: 494,228 (-2.8%).

Value
$514K
Shares
14,051
Price
$36.57
Role
CLO
Holding change
-2.8%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics Chief Commercial Officer Matthew T. Wiley Sells $113K of Stock

Matthew T. Wiley, Chief Commercial Officer, sold 3,097 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $113K in total on Sep 25, 2026. Shares held after the trade: 359,036 (-0.9%).

Value
$113K
Shares
3,097
Price
$36.57
Role
Chief Commercial Officer
Holding change
-0.9%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CEO Robert Barrow Sells $1.15M of Stock

Robert Barrow, CEO, sold 31,550 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $1.15M in total on Sep 25, 2026. Shares held after the trade: 2,213,090 (-1.4%).

Value
$1.15M
Shares
31,550
Price
$36.57
Role
CEO
Holding change
-1.4%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Becton Dickinson & Co BDX

Becton Dickinson & EVP, Chief Revenue Officer Michael Feld Sells $14K of Stock

Michael Feld, EVP, Chief Revenue Officer, sold 76 shares of Becton Dickinson & Co at $183.70 a share, worth $14K in total on Sep 28, 2026. Shares held after the trade: 19,644 (-0.4%).

Value
$14K
Shares
76
Price
$183.70
Role
EVP, Chief Revenue Officer
Holding change
-0.4%
Trade date
Sep 28, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CMO Daniel Karlin Sells $397K of Stock

Daniel Karlin, CMO, sold 10,853 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $397K in total on Sep 25, 2026. Shares held after the trade: 792,846 (-1.4%).

Value
$397K
Shares
10,853
Price
$36.57
Role
CMO
Holding change
-1.4%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Photronics Inc PLAB

Photronics SVP & GM of FPD Ops Han Kyung Park Sells $289K of Stock

Han Kyung Park, SVP & GM of FPD Ops, sold 9,500 shares of Photronics Inc at $30.37 a share, worth $289K in total on Sep 25, 2026. Shares held after the trade: 66,000 (-12.6%).

Value
$289K
Shares
9,500
Price
$30.37
Role
SVP & GM of FPD Ops
Holding change
-12.6%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Buying ADARx Pharmaceuticals, Inc. ADRX

ADARx Pharmaceuticals Director Simeon George Buys $27.2M of Stock

Simeon George, Director, bought 1,600,000 shares of ADARx Pharmaceuticals, Inc. at $17.00 a share, worth $27.2M in total on Sep 28, 2026. Shares held after the trade: 592,593.

Value
$27.2M
Shares
1,600,000
Average price
$17.00
Role
Director
Trade date
Sep 28, 2026
2:20 AM ET Form 4
Insider Buying ADARx Pharmaceuticals, Inc. ADRX

ADARx Pharmaceuticals 10% Owner Sr One Capital Management LLC Buys $27.2M of Stock

Sr One Capital Management LLC, 10% Owner, bought 1,600,000 shares of ADARx Pharmaceuticals, Inc. at $17.00 a share, worth $27.2M in total on Sep 28, 2026. Shares held after the trade: 592,593.

Value
$27.2M
Shares
1,600,000
Average price
$17.00
Role
10% Owner
Trade date
Sep 28, 2026
2:20 AM ET Form 4
Insider Selling Abeona Therapeutics Inc. ABEO

Abeona Therapeutics Chief Commercial Officer Madhav Vasanthavada Sells $25.3K of Stock

Madhav Vasanthavada, Chief Commercial Officer, sold 4,902 shares of Abeona Therapeutics Inc. at $5.16 a share, worth $25.3K in total on Sep 29, 2026. Shares held after the trade: 285,721 (-1.7%).

Value
$25.3K
Shares
4,902
Price
$5.16
Role
Chief Commercial Officer
Holding change
-1.7%
Trade date
Sep 29, 2026
2:20 AM ET Form 4
Insider Selling StoneX Group Inc. SNEX

StoneX Group CEO Philip Andrew Smith Sells $3.69M of Stock

Philip Andrew Smith, CEO, sold 56,250 shares of StoneX Group Inc. at $65.69 a share, worth $3.69M in total on Sep 28, 2026. Shares held after the trade: 738,216 (-7.1%).

Value
$3.69M
Shares
56,250
Price
$65.69
Role
CEO
Holding change
-7.1%
Trade date
Sep 28, 2026
2:20 AM ET Form 4
Insider Selling Abeona Therapeutics Inc. ABEO

Abeona Therapeutics SVP, CLO Brendan M. O'Malley Sells $34.7K of Stock

Brendan M. O'Malley, SVP, CLO, sold 6,727 shares of Abeona Therapeutics Inc. at $5.16 a share, worth $34.7K in total on Sep 29, 2026. Shares held after the trade: 421,226 (-1.6%).

Value
$34.7K
Shares
6,727
Price
$5.16
Role
SVP, CLO
Holding change
-1.6%
Trade date
Sep 29, 2026
2:20 AM ET Form 4
Insider Selling Abeona Therapeutics Inc. ABEO

Abeona Therapeutics CFO Joseph Walter Vazzano Sells $47.4K of Stock

Joseph Walter Vazzano, CFO, sold 9,191 shares of Abeona Therapeutics Inc. at $5.16 a share, worth $47.4K in total on Sep 29, 2026. Shares held after the trade: 482,888 (-1.9%).

Value
$47.4K
Shares
9,191
Price
$5.16
Role
CFO
Holding change
-1.9%
Trade date
Sep 29, 2026
2:20 AM ET Form 4
Insider Selling Abeona Therapeutics Inc. ABEO

Abeona Therapeutics CEO Vishwas Seshadri Sells $101K of Stock

Vishwas Seshadri, CEO, sold 19,608 shares of Abeona Therapeutics Inc. at $5.16 a share, worth $101K in total on Sep 29, 2026. Shares held after the trade: 1,286,500 (-1.5%).

Value
$101K
Shares
19,608
Price
$5.16
Role
CEO
Holding change
-1.5%
Trade date
Sep 29, 2026
5:31 PM ET 8-K
Investor Presentation FF EAI Robotics Ecosystem Inc. FFR

FF EAI Robotics Ecosystem Investor Presentation

AIxCrypto Holdings, Inc. has rebranded as FF EAI Robotics Ecosystem Inc. and filed a formal investor presentation detailing its strategic transition into the robotics sector. The presentation covers the company's business strategy and its proposed acquisition of the robotics business from its majority stockholder, Faraday Future Intelligent Electric Inc.

Counterparty
Faraday Future Intelligent Electric Inc.
5:31 PM ET 8-K
M&A Deal ONE Nuclear Energy Inc. ONEN

ONE Nuclear Energy M&A Deal with ONE Nuclear Energy, LLC

ONE Nuclear Energy Inc. (formerly Hennessy Capital Investment Corp. VII) completed its business combination with ONE Nuclear Energy, LLC on September 23, 2026. As a result of the merger, ONE Nuclear Energy, LLC became a wholly owned subsidiary of the company, which now trades on Nasdaq under the ticker ONEN. The transaction was primarily funded through the issuance of new common stock to the members of the target company.

Counterparty
ONE Nuclear Energy, LLC
5:30 PM ET 8-K
Dividend TPG Twin Brook Capital Income Fund

TPG Twin Brook Capital Income Fund Dividend

TPG Twin Brook Capital Income Fund declared monthly distributions for September 2026 of $0.2000 per share across all share classes, payable on October 28, 2026. The company also reported an aggregate net asset value (NAV) of $2.8 billion and a fair value investment portfolio of $5.3 billion as of August 31, 2026.

5:28 PM ET 8-K
Reverse Stock Split TruGolf Holdings, Inc. TRUG

TruGolf Holdings Reverse Stock Split

TruGolf Holdings, Inc. implemented a 1-for-10 reverse stock split of its common stock effective September 29, 2026. The split reduces the number of outstanding shares from approximately 12.44 million to 1.24 million and proportionally reduces authorized shares to 10.1 million to maintain compliance with Nevada statutes. The action is intended to consolidate shares and adjust the trading price on the Nasdaq Capital Market.

5:28 PM ET 8-K
Loan & Debt Pra Group Inc PRAA

Pra Group $400M Debt Financing

PRA Group, Inc. priced a private offering of $400.0 million in 8.500% senior notes due 2033. The company intends to use the net proceeds and available cash to repay approximately $400.0 million of outstanding borrowings under its North American revolving credit facility.

Value
$400M
Term
through 2033
5:26 PM ET 8-K
M&A Deal Silicon Valley Acquisition Corp. SVAQ

Silicon Valley Acquisition M&A Deal with EigenQ, Inc.

Silicon Valley Acquisition Corp. (SVAQ) and EigenQ, Inc. announced the public filing of a Form S-4 registration statement with the SEC regarding their previously announced business combination. The deal, which is expected to close in the fourth quarter of 2026, will result in EigenQ becoming a wholly owned subsidiary of a new Delaware corporation renamed EigenQ Holdings, Inc. (PubCo).

Counterparty
EigenQ, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.